Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Corcept Therapeutics › Officer exercised or converted 20K CORT derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Apr 7, 2026
Reporting period Not applicable
Filed with the SEC Apr 9, 2026 Officer Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001193125-26-148497
Filed / recorded
Apr 9, 2026, 3:34 AM UTC
Added to OQRO Oct 6, 2026, 7:14 PM UTC
Data quality Verified: identifiers matched exactly
Issuer CORCEPT THERAPEUTICS INC
Reporting person William Guyer
Officer title Chief Development Officer
Security Stock Option (right to buy)
Table Derivative (Table II)
Transaction date Apr 7, 2026
Acquired / disposed Disposed (D)
Shares owned after 190,000
Footnotes from the filing Fully exercisable. The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Feb 3, 2026 Insider Officer sold ~$817K of CORT shares in the open market Feb 24, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Mar 4, 2026 Insider Officer sold ~$296K of CORT shares in the open market Mar 17, 2026 Insider · 1 person Insiders: 2 purchases (~$3.3M) Mar 20, 2026 Insider Officer sold ~$424K of CORT shares in the open market Mar 25, 2026 Insider CEO sold ~$1.31M of CORT shares in the open market Apr 7, 2026 Insider Officer sold ~$819K of CORT shares in the open market What came next Apr 30, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors May 1, 2026 Insider CEO sold ~$2M of CORT shares in the open market May 5, 2026 Insider Officer sold ~$1.04M of CORT shares in the open market May 21, 2026 Company filing · Form 8-K · Executive change, Shareholder vote Changed a top executive or board member, and held a shareholder vote
“On May 21, 2026, Corcept Therapeutics Incorporated (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).”